bêta
IA Trial Radar

Découvrons ensemble les essais cliniques avec AstraZeneca en tant que promoteur principal ou collaborateur.

Les essais cliniques correspondant aux critères pour Diabète sont listés.

Je peux vous aider à comprendre votre état de santé, les traitements ou à trouver des essais cliniques près de chez vous.
Notre outil de recherche ne prend en charge que l'anglais. Pour la recherche et la discussion dans d'autres langues, utilisez l'IA Trial Radar ci-dessus ou sélectionnez les filtres de condition médicale et de lieu ci-dessous.
381 résultats trouvés
Affichage des 50 premiers
  
Pathologie
Diabète
×
 
Type
Médicament
×
 
Titre de l'étude
Statut
Renal Mechanism of Action/Splay vs. TmG (MOA) NCT00726505
Interrompu
Chinese Multiple Dose Escalation (MDE) High Dose Study (COTA China PK) NCT05437848
Terminé
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus NCT02229383
TerminéRésultats publiés
Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus NCT00108004
Terminé
Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin NCT00701935
InterrompuRésultats publiés
Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes NCT00064714
Terminé
Investigate the Effect of AZD1656 on the Pharmacokinetics of Sitagliptin in Patients With Type 2 Diabetes Mellitus NCT01095991
Terminé
Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes Mellitus NCT01082120
Terminé
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo NCT02229396
TerminéRésultats publiés
A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With Type 2 Diabetes Mellitus (IRAK4) NCT07433062
En recrutement
Impact of Diabetes on Left Ventricular Remodeling (P3) NCT01052272
TerminéRésultats publiés
Efficacité, sécurité et tolérabilité de l'administration orale une fois par jour d'AZD5004 par rapport au placebo pendant 26 semaines chez des adultes atteints de diabète sucré de type 2. (SOLSTICE) NCT06579105
Terminé
Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus NCT02500979
TerminéRésultats publiés
A 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone NCT02419612
TerminéRésultats publiés
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus (T2DM) Aged 10 to Below 18 Years Old NCT03199053
TerminéRésultats publiés
Evaluation of the Effect of Pramlintide on Satiety and Food Intake NCT00042601
Terminé
To Assess Safety of Fixed Dose Combination of Dapagliflozin and Saxagliptin in Type 2 Diabetes Mellitus Patients NCT04445714
TerminéRésultats publiés
A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas NCT00313313
TerminéRésultats publiés
Japan Dose Regimen Study of AZD1656 in Japanese Type 2 Diabetes Mellitus Patients NCT01152385
TerminéRésultats publiés
Study of BMS-477118 as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise NCT00316082
TerminéRésultats publiés
An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes NCT00229658
TerminéRésultats publiés
Trial to Evaluate the Efficacy and Safety of Dapagliflozin in Japanese Type 2 Diabetes Mellitus Patients NCT00972244
TerminéRésultats publiés
A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise NCT00327015
TerminéRésultats publiés
Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) Patients NCT01020123
TerminéRésultats publiés
Efficacy of 500µg Roflumilast Once Daily Versus Placebo Over 12 Weeks in Patients With Diabetes Mellitus Type 2. A Double Blind, Parallel Group, Proof of Concept Clinical Study (FORTUNA) NCT01140542
Terminé
Phase III Insulin Add-On Asia Regional Program - ST NCT02096705
TerminéRésultats publiés
A Study to Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes Mellitus NCT00313183
Terminé
Effects of Dapagliflozin 10 mg on Insulin Resistance in Patients With Type 2 Diabetes Mellitus (DERISC) NCT02426541
TerminéRésultats publiés
Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes Mellitus NCT01206647
Inconnu
A Phase I Study to Assess the Pharmacodynamics of Oral AR-C165395XX in Subjects With Type 2 Diabetes Mellitus (T2DM) NCT02367066
TerminéRésultats publiés
Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease (PLANET 1) NCT00296374
TerminéRésultats publiés
Effects of Rosuvastatin on the, in Vivo, Kinetic of apoB and apoA1, Using Stable Isotopes, in Type 2 Diabetic Patients NCT00658463
Terminé
Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP) NCT06099067
Terminé
Characterization of the Kinetics of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus (T2DM) NCT01165268
Terminé
Dapagliflozin, Cardio-Metabolic Risk Factors and Type-2 Diabetes NCT03377335
Inconnu
Bioequivalence Study NCT01874080
Terminé
GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 Diabetes NCT00229710
Interrompu
Study to Assess the Effect on Glucose Homeostasis of Two Dose Levels of AZD9567, Compared to Prednisolone, in Adults With Type 2 Diabetes NCT04556760
TerminéRésultats publiés
A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus (THEMIS) NCT01991795
TerminéRésultats publiés
Drug-drug Interaction Study of Dapagliflozin With Voglibose in Japanese Type 2 Diabetes Mellitus Patients NCT01055652
Terminé
GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus NCT00226330
Interrompu
Evaluation of the Bioavailability of Pramlintide NCT00042471
Terminé
An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus NCT00135330
TerminéRésultats publiés
An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Daily to Patients With Type 2 Diabetes Mellitus NCT01876849
Terminé
Saxagliptin Compared to Glimepiride in Elderly Type 2 Diabetes Patients, With Inadequate Glycemic Control on Metformin (GENERATION) NCT01006603
TerminéRésultats publiés
Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes (DEPICT 1) NCT02268214
TerminéRésultats publiés
Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes (DEPICT 2) NCT02460978
TerminéRésultats publiés
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus NCT00107107
Terminé
Efficacy and Tolerability of Saxagliptin add-on Compared to Uptitration of Metformin in Patients With Type 2 Diabetes (PROMPT) NCT01006590
TerminéRésultats publiés
Effect of DapagliFLOzin on Quality of Life in Patients With Type 2 Diabetes in a Real Clinical PrActice (FLORA) NCT02719132
Retiré